S&P 500, Nasdaq-100 futures tick higher after GDP, jobless claims data
U.S. stock futures moved marginally higher on Thursday following the latest flurry of U.S. economic reports. Investors received the first reading on Q4 GDP. The data showed the U.S. economy expanded ...
Jim Cramer Says Microsoft Corporation (MSFT) Has ‘Not Been A Winner’
We recently compiled a list of the Jim Cramer Discussed These 11 Stocks Before The DeepSeek Sell-Off. In this article, we are ...
Mizuho raises Sage Therapeutics target to $9 on Biogen bid
Securities adjusted its outlook on Sage Therapeutics (NASDAQ:SAGE) shares, with analyst Vamil Divan increasing the price target to $9.00 from the previous $6.00, while maintaining a Neutral rating on ...
Stock Market Today: Nasdaq Futures Gain Ahead of GDP Report, Apple Earnings
Follow along for live updates on stocks, bonds and other markets, including the Dow Jones Industrial Average, S&P 500 and Nasdaq Composite.
Jim Cramer on NVIDIA Corporation (NVDA): ‘It’s Doing Nothing!’
We recently compiled a list of the Jim Cramer Discussed These 11 Stocks Before The DeepSeek Sell-Off. In this article, we are going to take a look at where NVIDIA Corporation (NASDAQ:NVDA) stands ...
5 Things to Know Before the Stock Market Opens
U.S. stock futures point mostly higher as investors react to corporate earnings, Apple is slated to report results after the bell, and Tesla stock gains after the company delivers an upbeat update on ...
Jim Cramer Says ‘But There Is A Sense That Tesla, Inc. (TSLA) Is The Way To Play Robot’
We recently compiled a list of the Jim Cramer Discussed These 11 Stocks Before The DeepSeek Sell-Off. In this article, we are ...
Oppenheimer sets Alumis stock with Outperform, $32 target
Oppenheimer initiated coverage on Alumis Inc (NASDAQ:ALMS) with an Outperform rating and a price target of $32.00. The firm's analysts highlighted the biopharmaceutical company's focus on developing ...
Bernstein raises Alphabet stock price target to $210
Bernstein analysts at SocGen Group adjusted their outlook on Alphabet Inc. (NASDAQ:GOOGL) by increasing the price target from $185.00 to $210.00, while maintaining a Market Perform rating on the ...
What's Wrong With Iovance Biotherapeutics Stock?
It was about a year ago that shares of Iovance Biotherapeutics (NASDAQ: IOVA) began to take off. Could this be a great buying ...
Nvidia: DeepSeek Isn't Going To Topple The AI Gravy Train
Nvidia’s AI leadership remains intact, despite DeepSeek concerns. Read why NVDA stock’s steep drop represents a great ...